Skip Navigation

Profile

Jeffrey Rogers, M.D.Wake Forest Baptist Health

Doctor Rating

4.7 out of 5

52 Ratings
9 Comments
 

Jeffrey Rogers, M.D.

Program Director, Surgical Sciences-Transplant
Professor, Surgical Sciences-Transplant

Clinical Interests

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, General Surgery, Transplant Surgery

Contact Information

Returning Patient Appointments: 336-716-0548
Department: 336-716-0548

Email: jerogers@wakehealth.edu

Insurance Accepted »

Education & Training

  • B.A., University of Pennsylvania, 1986
  • M.D., Albert Einstein College of Medicine, 1990
  • Residency, Montefiore Hosp/Med Ctr, 1995
  • Fellowship, Transplant Surgery, Univ of Pitt Sch of Medicine, 1996
  • Fellowship, Transplantation Immunology, Univ of Pitt Sch of Medicine, 1997
  • Fellowship, Transplant Surgery, Univ of Pitt Sch of Medicine, 1999

Board Certifications

  • American Board of Surgery, Surgery

NPI Number

  • 1073598140
Jeffrey Rogers, M.D.

Doctor Rating

4.7 out of 5

52 Ratings
9 Comments
 

Jeffrey Rogers, M.D.

Program Director, Surgical Sciences-Transplant
Professor, Surgical Sciences-Transplant
Institute for Regenerative Medicine

Research Interests

Kidney Transplantation; Pancreas Transplantation; Tissue Donors; Graft Survival; Kidney Failure, Chronic
More »

Contact Information

Academic: 336-716-0548 | Department: 336-716-0548

Email: jerogers@wakehealth.edu

Recent Publications

Experience with alemtuzumab induction with tacrolimus/mycophenolate +/- steroids in simultaneous pancreas-kidney transplant (SPKT) recipients with portal-enteric (P-E) drainage [abstract]. Harriman D, Farney A, Rogers J, Orlando G, El-Hennawy H, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2018;18(Suppl 2):98.

Does prolonged cold ischemia affect outcomes in donation after cardio-circulatory death (DCD) kidney transplants? [abstract]. Harriman D, Rogers J, Khan M, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2018;18(Suppl 2):39.

Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors?. Orlando G, Khan MA, El-Hennawy H, Farney AC, Rogers J, Reeves-Daniel A, Gautreaux MD, Doares W, Kaczmorski S, Stratta RJ.. Clin Transplant. 2018;32(3):e13185.

Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard. Khan MA, El-Hennawy H, Jones KC, Harriman D, Farney AC, Rogers J, Orlando G, Stratta RJ.. Clin Transplant. 2018;32(6):e13275.

Long-term follow-up of pediatric kidney recipients who received alemtuzumab induction [abstract]. Harriman D, Chen A, Rogers J, Stratta R, Orlando G, South A, Lin JJ, Farney A.. Am J Transplant. 2018;18(Suppl 4):702.

Experience with alemtuzumab induction with tacrolimus/mycophenolate plus /- steroids in simultaneous pancreas-kidney transplant recipients with portal-enteric drainage [abstract]. Harriman D, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2018;18(Suppl 4):596.

High kidney donor profile index (KDPI) donor kidneys: use them, don't lose them! [abstract]. Harriman D, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2018;18(Suppl 4):930.

Does pre-operative angiographic kidney embolization decrease complications in allograft nephrectomy? [abstract]. Harriman D, Mujumdar V, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Stratta R.. Am J Transplant. 2018;18(Suppl 4):911.

Does prolonged cold ischemia affect outcomes in donation after cardiac death kidney transplants? [abstract]. Harriman D, Rogers J, Farney A, Orlando G, Reeves-Daniel A, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2018;18(Suppl 4):661.

Should kidneys from donation after cardiac death expanded criteria donors be transplanted? [abstract]. Harriman D, Rogers J, Farney A, Orlando G, Reeves-Daniel A, Gautreaux M, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2018;18(Suppl 4):667-668.

Kidney exchange to overcome financial barriers to kidney transplantation. Rees MA, Dunn TB, Kuhr CS, Marsh CL, Rogers J, Rees SE, Cicero A, Reece LJ, Roth AE, Ekwenna O, Fumo DE, Krawiec KD, Kopke JE, Jain S, Tan M, Paloyo SR.. Am J Transplant. 2017;17(3):782-790.

Global kidney exchange [abstract]. Rees M, Dunn T, Rees S, Rogers J, Reece L, Roth A, Kuhr C, Ekwenna O, Fumo D, Krawiec K, Jain S, Marsh C, Cicero A, Kopke J, Tan M, Paloyo S.. Am J Transplant. 2017;17(Suppl 2):60.

Should ECD kidneys be used in retransplantation? [abstract]. Alradawna B, Khan M, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2017;17(Suppl 2):51.

Severe intellectual disability is not a contraindication to kidney transplantation in children. Chen A, Farney A, Russell GB, Nicolotti L, Stratta R, Rogers J, Lin JJ.. Pediatr Transplant. 2017;21(3):e12887.

Lack of utility of KDPI in dual kidneys from donors at the extremes of age [abstract]. McCullough MA, Khan M, Alradawna B, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2017;17(Suppl 2):47.

Clinical yield of endoscopic ultrasound and endoscopic ultrasound-guided fine-needle aspiration for incidental pancreatic cysts in kidney transplant evaluation. Rejeski J, Rogers J, Hauser M, Mishra G.. Clin Transplant. 2017;31(7):e12999.

Analysis of local versus imported expanded criteria donor kidneys: a single-center experience with 497 ECD kidney transplants. Khan MA, El-Hennawy H, Farney AC, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta RJ.. Clin Transplant. 2017;31(8):e13029.

Lack of utility of KDPI in dual kidneys from donors at the extremes of age [abstract]. Felts D, Khan M, Alradawna B, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Doares W, Kaczmorski S, Stratta J.. Am J Transplant. 2017;17(Suppl 3):443-444.

Kidney re-transplantation (KRTx) from donation after cardiocirculatory death (DCD)-standard criteria donors (SCD) [abstract]. Khan M, Alradawna B, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Doares W, Kaczmorsky S, Stratta R.. Am J Transplant. 2017;17(Suppl 3):625.

Global kidney exchange [abstract]. Rees M, Dunn T, Rees S, Rogers J, Roth A, Kuhr C, Ekwenna O, Krawiec K, Jain S, Marsh C, Sindhwani P, Zimmerman M, Forbes R, Tan M, Ashlagi I, Correa-Rotter R, Paloyo S.. Am J Transplant. 2017;17(Suppl 3):812.

Global kidney exchange: a case study [abstract]. Paloyo S, Dunn T, Kuhn C, Marsh C, Rogers J, Rees S, Cicero A, Reece L, Roth A, Ekwenna O, Fumo D, Krawiec K, Kopke J, Jain S, Tan M, Rees M.. Transpl Int. 2017;30(Suppl 2):171.

AKI and DCD kidneys as a research platform for kidney regeneration and repair: bridging regenerative medicine to organ transplantation [abstract]. Orlando G, Danger R, Okut H, Bussolati B, Edgar L, Gall E, Tamburrini R, Farney A, Rogers J, Stratta R, Brouard S, Walker S, Bergman C.. Transpl Int. 2017;30(Suppl 2):555.

Kidney transplantation, bioengineering and regeneration: an originally immunology-based discipline destined to transition towards ad hoc organ manufacturing and repair. Rogers J, Katari R, Gifford S, Tamburrini R, Edgar L, Voigt MR, Murphy SV, Igel D, Mancone S, Callese T, Colucci N, Mirzazadeh M, Peloso A, Zambon JP, Farney AC, Stratta RJ, Orlando G.. Expert Rev Clin Immunol. 2016;12(2):169-182.

The human pancreas as a source of protolerogenic extracellular matrix scaffold for a new-generation bioartificial endocrine pancreas. Peloso A, Urbani L, Cravedi P, Katari R, Maghsoudlou P, Fallas ME, Sordi V, Citro A, Purroy C, Niu G, McQuilling JP, Sittadjody S, Farney AC, Iskandar SS, Zambon JP, Rogers J, Stratta RJ, Opara EC, Piemonti L, Furdui CM, Soker S, De Coppi P, Orlando G.. Ann Surg. 2016;264(1):169-179.

APOL1 genotype and kidney transplantation outcomes from deceased African American donors. Freedman BI, Pastan SO, Israni AK, Schladt D, Julian BA, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Bowden DW, Hicks PJ, Palmer ND,.. Transplantation. 2016;100(1):194-202.

Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? [abstract]. Carrier A, Kahn MA, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):43.

Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard [abstract]. Jones K, Khan A, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 1):44.

Differential effect of delayed graft function on kidney transplant outcomes [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Brim E, Hairston G, Mangus M, Stratta R.. Am J Transplant. 2016;16(Suppl 1):53.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Palanisamy A, Reeves-Daniel A, Stratta R.. Am J Transplant. 2016;16(Suppl 1):54.

Single vs dual (en bloc) kidney transplants from donors less than or equal to 5 years of age: a single center experience. Al-Shraideh Y, Farooq U, El-Hennawy H, Farney AC, Palanisamy A, Rogers J, Orlando G, Khan M, Reeves-Daniel A, Doares W, Kaczmorski S, Gautreaux MD, Iskandar SS, Hairston G, Brim E, Mangus M, Stratta RJ.. World J Transplant. 2016;6(1):239-248.

Single-center experience with deceased donor kidney transplantation in 114 individuals aged 70 and older in the new millennium [letter]. Stratta RJ, Farney AC, Palanisamy A, Rogers J, Orlando G, Reeves-Daniel A.. J Am Geriatr Soc. 2016;64(11):e219-e221.

Why are pancreas transplants declining in the United States in the past decade? [abstract]. Stratta R, Gruessner A, Odorico J, Fridell J, Rogers J, Farney A, Orlando, G, Gruessner R.. Am J Transplant. 2016;16(Suppl 3):518.

Is prolonged cold ischemia a contraindication to using kidneys from acute kidney injury donors? [abstract]. Khan M, Carrier A, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):300.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Islandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):399.

Differential effect of delayed graft function (DGF) on kidney transplant outcomes: when does DGF not make a difference? [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):738-739.

Influence of pancreas import and cold ischemia on outcomes following pancreas transplantation [abstract]. Khan M, El-Hennawy H, Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2016;16(Suppl 3):421.

Pediatric en bloc kidney transplants reduce DGF and are misrepresented by the KDPI [abstract]. Khan M, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):568.

Outcomes of deceased donor kidney transplantation from diabetic donors: does presence of recipient diabetes matter? [abstract]. Rogers J, Farney A, Orlando G, Reeves-Daniel A, Palanisamy A, El-Hennawy H, Khan M, Gautreaux M, Iskandar S Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):569-570.

Managing the kidney waiting list: pride and prejudice [abstract]. Smith F, Sheehan C, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2016;16(Suppl 3):629.

Eversion endarterectomy of the deceased donor renal artery to prevent kidney discard [abstract]. Khan M, Jones K, El-Hennawy H, Farney A, Rogers J, Orlando G, Stratta R.. Am J Transplant. 2016;16(Suppl 3):569.

Does donor and recipient age disparity make a difference with expanded criteria donors? [abstract]. Khan M, Jones K, El-Hennawy H, Farney A, Rogers J, Orlando G, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Stratta R.. Am J Transplant. 2016;16(Suppl 3):627.

Role of allograft nephrectomy following kidney graft failure: preliminary experience with pre-operative angiographic kidney embolization. Al-Geizawi SM, Singh RP, Zuckerman JM, Requarth JA, Farney AC, Rogers J, Taussig J, Orlando G, Stratta RJ.. J Nephrol. 2015;28(3):379-385.

Simultaneous transplantation of the living donor kidney and deceased donor pancreas and other transplant options for diabetic and uremic patients. Farney AC, Rogers J, Orlando G, Stratta RJ.. Curr Opin Organ Transplant. 2015;20(1):103-107.

Does prolonged cold ischemia influence outcomes following pancreas transplantation? [abstract]. El Hennawy H, Rogers J, Farney A, Orlando G, Kahn M, Reeves-Daniel A, Palanisamy A, Stratta R.. Am J Transplant. 2015;15(Suppl 1):112.

Analysis of local versus imported expanded criteria donor (ECD) kidneys: a single center experience with 497 ECD kidney transplants [abstract]. El Hennawy H, Farney A, Orlando G, Rogers J, Khan M, Reeves-Daniel A, Palanisamy A, Gautreaux M, Iskandar S, Doares W, Kaczmorski S, Mangus M, Stratta R.. Am J Transplant. 2015;15(Suppl 1):75.

Prospect for kidney bioengineering: shortcomings of the status quo. Peloso A, Katari R, Murphy SV, Zambon JP, DeFrancesco A, Farney AC, Rogers J, Stratta RJ, Manzia TM, Orlando G.. Expert Opin Biol Ther. 2015;15(4):547-558.

Discarded human pancreas as source of ECM scaffold for a new generation bio-artificial endocrine pancreas [abstract]. Peloso A, Katari R, Urbani L, Maghsoudlou P, Fallas MEA, Citro A, Delario G, Willis C, Farney A, Rogers J, Stratta R, Peimonti L, Soker S, Orlando G.. Am J Transplant. 2015;15(Suppl 1):49.

Pancreas transplantation in C-peptide positive patients: does 'type' of diabetes really matter?. Stratta RJ, Rogers J, Farney AC, Orlando G, El-Hennawy H, Gautreaux MD, Reeves-Daniel A, Palanisamy A, Iskandar SS, Bodner JK.. J Am Coll Cardiol. 2015;220(4):716-727.

Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure. Freedman BI, Julian BA, Pastan SO, Israni AK, Schladt D, Gautreaux MD, Hauptfeld V, Bray RA, Gebel HM, Kirk AD, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Mohan S, Ma L, Langefeld CD, Hicks PJ, Palmer ND, Adams PL,.. Am J Transplant. 2015;15(6):1615-1622.

Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation. Ma J, Divers J, Palmer ND, Julian BA, Israni AK, Schladt D, Pastan SO, Chattrabhuti K, Gautreaux MD, Hauptfeld V, Bray RA, Kirk AD, Brown WM, Gaston RS, Rogers J, Farney AC, Orlando G, Stratta RJ, Guan M, Palanisamy A, Reeves-Daniel AM, Bowden DW,.. Kidney Int. 2015;88(3):584-592.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Surgical Sciences-Transplant

Clinical Interests

Dialysis Access, Kidney Transplantation, Pancreas Transplantation, General Surgery, Transplant Surgery
Jeffrey Rogers, M.D.

Jeffrey Rogers, M.D.

Program Director, Surgical Sciences-Transplant
Professor, Surgical Sciences-Transplant
Institute for Regenerative Medicine

Doctor Rating

4.7 out of 5

Jeffrey Rogers, M.D.52 Ratings
9 Comments


 

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.7
CP explanations of prob/condition
4.8
CP spoke using clear language
4.8
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.8
Patients' confidence in CP
4.8
Time CP spent with patient
4.8
Wait time at clinic
4.3



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

5/1/2018

*Dr. Rogers is a pleasant, caring professional physician. My visit with him was positive and helpful.

3/31/2018

Dr.Rodgers was very nice & I felt more at ease after he explained to me my situation & surgery needed . Hope to meet with him during my future appts.

3/28/2018

Very professional and understanding to my healthcare needs.

3/21/2018

Great Care Provider. Listened very well to concerns. Gave excellent advice/information

1/23/2018

I have recommended to friends and family everyone from the transplant team to the custodians.

8/24/2017

*Dr. Rogers was great!

8/3/2017

All the persons work well together and keep the patients welfare first - always.

7/26/2017

Good.

7/24/2017

No bad.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Wake Forest Baptist Ranked among Nation’s ‘Best Hospitals’  25 Years in a Row by U.S. News & World ReportComprehensive Cancer Centers National Designation is Renewed2017-2018 Best DoctorsNursing Magnet StatusJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.

© Wake Forest Baptist Medical Center, Medical Center Boulevard, Winston-Salem, NC 27157. All Rights Reserved.